These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 31316523)
21. International definition of iMCD-TAFRO: future perspectives. Nishimura Y; Nishimura MF; Sato Y J Clin Exp Hematop; 2022 Jun; 62(2):73-78. PubMed ID: 35474036 [TBL] [Abstract][Full Text] [Related]
22. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids. Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221 [TBL] [Abstract][Full Text] [Related]
23. Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review. Tanaka M; Tsujimoto H; Yamamoto K; Shimoda S; Oka K; Takeoka H Medicine (Baltimore); 2017 Oct; 96(40):e8216. PubMed ID: 28984775 [TBL] [Abstract][Full Text] [Related]
24. [Thrombotic microangiopathy developing subsequent to tocilizumab therapy in a patient with TAFRO syndrome]. Ito S; Tsutsumi Y; Kikuchi R; Matsuoka S; Shimoyama N Rinsho Ketsueki; 2018; 59(11):2432-2437. PubMed ID: 30531139 [TBL] [Abstract][Full Text] [Related]
25. Serial Manifestation of Acute Kidney Injury and Nephrotic Syndrome in a Patient with TAFRO Syndrome. Ito S; Uchida T; Itai H; Yamashiro A; Yamagata A; Matsubara H; Imakiire T; Shimazaki H; Kumagai H; Oshima N Intern Med; 2018 Nov; 57(21):3129-3133. PubMed ID: 29877281 [TBL] [Abstract][Full Text] [Related]
26. TAFRO Syndrome. Igawa T; Sato Y Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612 [TBL] [Abstract][Full Text] [Related]
27. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease? Takai K Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540266 [TBL] [Abstract][Full Text] [Related]
28. [A case report of TAFRO syndrome]. Zhou GP; Zhou QY; Zhu JH Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):814-817. PubMed ID: 34393252 [TBL] [Abstract][Full Text] [Related]
29. Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review. Belyaeva E; Rubenstein A; Pierson SK; Dalldorf D; Frank D; Lim MS; Fajgenbaum DC Hematol Oncol; 2022 Apr; 40(2):191-201. PubMed ID: 35104370 [TBL] [Abstract][Full Text] [Related]
30. Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage. Noda Y; Saka Y; Kato A; Mimura T; Naruse T Clin Nephrol Case Stud; 2018; 6():16-20. PubMed ID: 30009125 [TBL] [Abstract][Full Text] [Related]
31. TAFRO Syndrome: A Case of Significant Endocrinopathy in a Caucasian Patient. Miatech JL; Patel NR; Latuso NQ; Ellipeddi PK Cureus; 2019 Jun; 11(6):e4946. PubMed ID: 31453020 [TBL] [Abstract][Full Text] [Related]
32. Association of vascular endothelial growth factor and renal thrombotic microangiopathy-like lesions in patients with Castleman's disease. Sun PP; Yu XJ; Wang SX; Zhou XJ; Qu L; Zhang F; Ma YY; Liu G; Yang L Nephrology (Carlton); 2020 Feb; 25(2):125-134. PubMed ID: 31264312 [TBL] [Abstract][Full Text] [Related]
33. Biomarkers and Signaling Pathways Implicated in the Pathogenesis of Idiopathic Multicentric Castleman Disease/Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly (TAFRO) Syndrome. Sumiyoshi R; Koga T; Kawakami A Biomedicines; 2024 May; 12(6):. PubMed ID: 38927348 [TBL] [Abstract][Full Text] [Related]
35. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report. Fujiwara Y; Ito K; Takamura A; Nagata K J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532 [TBL] [Abstract][Full Text] [Related]
36. Pathological evaluation of renal complications in children following allogeneic hematopoietic stem cell transplantation: a retrospective cohort study. Chen RY; Li XZ; Lin Q; Tang HY; Cui NX; Jiang L; Dai XM; Chen WQ; Deng F; Hu SY; Zhu XM BMC Pediatr; 2023 Apr; 23(1):186. PubMed ID: 37085779 [TBL] [Abstract][Full Text] [Related]
37. The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome. Kurose N; Guo X; Shioya A; Mizutani KI; Kumagai M; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Nakamura S; Yamada S Pathol Res Pract; 2019 Oct; 215(10):152563. PubMed ID: 31358479 [TBL] [Abstract][Full Text] [Related]
38. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review. Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072 [TBL] [Abstract][Full Text] [Related]
39. TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report. Iwasaki T; Mizusaki K; Masumoto M; Minagawa Y; Azuma K; Furukawa T; Yoshida M; Kuragano T BMC Nephrol; 2022 Jul; 23(1):262. PubMed ID: 35870879 [TBL] [Abstract][Full Text] [Related]
40. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients. Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]